About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Hormone Therapy may Improve Thinking for Postmenopausal Women

by Chrisy Ngilneii on June 1, 2018 at 3:06 PM
Font : A-A+

Hormone Therapy may Improve Thinking for Postmenopausal Women

Hormone therapy may slow down cognitive decline among women who have gone through menopause.

Recent study finds that transdermal estradiol in combination with an oral progesterone may improve cognitive function in postmenopausal women.

Advertisement


It comes as no surprise that cognitive function declines as we age. We recognize memory decline in a number of ways, such as not being able to remember a grocery list as easily as we once did. Mild cognitive impairment (MCI) is defined as that intermediate stage between normal aging and dementia. Persons with MCI have an increased risk of progressing to Alzheimer disease or other dementia, with roughly 20 percent of this population crossing over from MCI to a more severe level each year. To date, no pharmacologic treatment has proven effective in managing MCI.

The article "Menopausal hormone therapy and mild cognitive impairment: a randomized, placebo-controlled trial" reviews the results from a recent Korean study regarding the effect of hormone therapy on cognitive function. The study followed postmenopausal women who were diagnosed with MCI and taking donepezil over a 24-month period and showed that cognitive test scores for the women who received hormone therapy significantly increased during that time. Although the study group was small, the study offers promising results, demonstrating that the combination of transdermal estradiol and an oral progesterone can slow down cognitive decline. This is the first known study to evaluate the effect of hormone therapy on MCI.
Advertisement

"This encouraging, small pilot trial suggests a possible benefit of hormone therapy when given to women diagnosed with MCI who are also taking donepezil, a cholinesterase inhibitor," says Dr. JoAnn Pinkerton, executive director of NAMS. "Higher global cognition was seen in two of the three key evaluation criteria in those women using estradiol gel plus an oral micronized progesterone compared with those in the placebo group. Larger trials are needed to evaluate the effect of hormone therapy use before the full onset of Alzheimer disease."

The study is published in Menopause, the journal of The North American Menopause Society (NAMS).

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Cochlear Implants may Consequently Drive Hearing Loss
E-cigarettes Use Linked to Erectile Dysfunction
Memory Loss - Can it be Recovered?
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Menopause Dilatation and Curettage Reiki and Pranic Healing 

Recommended Reading
Menopause Homeopathy Treatment
Homeopathy is a risk-free, effective and non-hormonal treatment for the problems associated with ......
Hormone Replacement Therapy
Hormone Replacement Therapy can be likened to an 'oasis in the desert' for women in the throes of .....
Menopause
Menopause is defined as the state of permanent cessation of menstrual cycles (periods) for ......
Health Screening for Women
Health screening in women between 40 and 60 years helps to diagnose health issues in the early ......

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use